# NELARABINE

NDC: 46708-813
Generic name: nelarabine
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20240801

FDA application: ANDA218554

## Active ingredients

- NELARABINE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-813"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-813
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03ad6056-0e71-4e7c-842a-a5f87649bdcd